Matches in SemOpenAlex for { <https://semopenalex.org/work/W1603290129> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W1603290129 endingPage "O50" @default.
- W1603290129 startingPage "O50" @default.
- W1603290129 abstract "7-11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK S/GSK1349572, a next-generation HIV-1 integrase inhibitor, has previously demonstrated potent antiviral activity in Phase 2a with once-daily, unboosted dosing. SPRING-1 is an ongoing dose-ranging study designed to select a dose to for Phase 3 evaluation. SPRING-1 is a Phase 2b, multicentre, partially-blinded study in therapy-naïve adults, randomized 1:1:1:1 to 10mg, 25mg or 50mg of S/GSK1349572 or efavirenz(EFV) 600mg once-daily with either co-formulated TDF/FTC or ABC/3TC. 205 subjects received study drug: 86% male, 20% non-white, 26%>100,000c/mL HIV-1 RNA, 67% TDF/FTC. Plasma HIV-1 RNA declined rapidly across all S/GSK1349572 doses with no differences in NRTI subgroups. Three protocol-defined virologic failures occurred, 1 on EFV (<1log10 decline by Week 4), and 2 on S/GSK1349572 (Week 4 and 24 rebound >400c/mL with no INI mutation detected). No dose-related clinical or laboratory toxicities were observed. More drug-related AEs of moderate-or-higher intensity were reported on EFV (20%) than S/GSK1349572 (6%) arms; none occurred in more than 1 S/GSK1349572 subject. The most frequent category of such events reported by subjects receiving EFV and S/GSK1349572 were gastrointestinal (4% vs. 2%, respectively); other frequent events on EFV were psychiatric (6%) and rash (4%) disorders. No SAE was considered related to S/GSK1349572. Six subjects (2: S/GSK1349572 and 4: EFV) withdrew due to AEs. Mean change from baseline in LDL cholesterol was +0.023mmol/L among S/GSK1349572 subjects and +0.468mmol/L among EFV subjects. S/GSK1349572 demonstrated low pharmacokinetic variability and drug exposure increased with dose. Table 1 S/GSK1349572 administered once-daily without a PK booster was well tolerated with potent antiviral activity at all doses explored in SPRING-1. The greater CD4+ cell increases on S/GSK1349572 merit further observation and confirmation." @default.
- W1603290129 created "2016-06-24" @default.
- W1603290129 creator A5009217976 @default.
- W1603290129 creator A5042520883 @default.
- W1603290129 creator A5048162351 @default.
- W1603290129 creator A5049568112 @default.
- W1603290129 creator A5054617732 @default.
- W1603290129 creator A5056578595 @default.
- W1603290129 creator A5064337611 @default.
- W1603290129 creator A5067346338 @default.
- W1603290129 creator A5067869984 @default.
- W1603290129 creator A5085992339 @default.
- W1603290129 date "2010-11-01" @default.
- W1603290129 modified "2023-10-17" @default.
- W1603290129 title "Once-daily S/GSK1349572 combination therapy in antiretroviral-naïve adults: rapid and potent 24-week antiviral responses in SPRING-1 (ING112276)" @default.
- W1603290129 doi "https://doi.org/10.1186/1758-2652-13-s4-o50" @default.
- W1603290129 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3112866" @default.
- W1603290129 hasPublicationYear "2010" @default.
- W1603290129 type Work @default.
- W1603290129 sameAs 1603290129 @default.
- W1603290129 citedByCount "8" @default.
- W1603290129 countsByYear W16032901292012 @default.
- W1603290129 countsByYear W16032901292013 @default.
- W1603290129 crossrefType "journal-article" @default.
- W1603290129 hasAuthorship W1603290129A5009217976 @default.
- W1603290129 hasAuthorship W1603290129A5042520883 @default.
- W1603290129 hasAuthorship W1603290129A5048162351 @default.
- W1603290129 hasAuthorship W1603290129A5049568112 @default.
- W1603290129 hasAuthorship W1603290129A5054617732 @default.
- W1603290129 hasAuthorship W1603290129A5056578595 @default.
- W1603290129 hasAuthorship W1603290129A5064337611 @default.
- W1603290129 hasAuthorship W1603290129A5067346338 @default.
- W1603290129 hasAuthorship W1603290129A5067869984 @default.
- W1603290129 hasAuthorship W1603290129A5085992339 @default.
- W1603290129 hasBestOaLocation W16032901291 @default.
- W1603290129 hasConcept C126322002 @default.
- W1603290129 hasConcept C142462285 @default.
- W1603290129 hasConcept C159047783 @default.
- W1603290129 hasConcept C2777288759 @default.
- W1603290129 hasConcept C2777302000 @default.
- W1603290129 hasConcept C2778570526 @default.
- W1603290129 hasConcept C2781432083 @default.
- W1603290129 hasConcept C2993143319 @default.
- W1603290129 hasConcept C3013748606 @default.
- W1603290129 hasConcept C71924100 @default.
- W1603290129 hasConcept C98274493 @default.
- W1603290129 hasConceptScore W1603290129C126322002 @default.
- W1603290129 hasConceptScore W1603290129C142462285 @default.
- W1603290129 hasConceptScore W1603290129C159047783 @default.
- W1603290129 hasConceptScore W1603290129C2777288759 @default.
- W1603290129 hasConceptScore W1603290129C2777302000 @default.
- W1603290129 hasConceptScore W1603290129C2778570526 @default.
- W1603290129 hasConceptScore W1603290129C2781432083 @default.
- W1603290129 hasConceptScore W1603290129C2993143319 @default.
- W1603290129 hasConceptScore W1603290129C3013748606 @default.
- W1603290129 hasConceptScore W1603290129C71924100 @default.
- W1603290129 hasConceptScore W1603290129C98274493 @default.
- W1603290129 hasLocation W16032901291 @default.
- W1603290129 hasLocation W16032901292 @default.
- W1603290129 hasOpenAccess W1603290129 @default.
- W1603290129 hasPrimaryLocation W16032901291 @default.
- W1603290129 hasRelatedWork W1964545773 @default.
- W1603290129 hasRelatedWork W2034470753 @default.
- W1603290129 hasRelatedWork W2106737113 @default.
- W1603290129 hasRelatedWork W2108992076 @default.
- W1603290129 hasRelatedWork W2109360985 @default.
- W1603290129 hasRelatedWork W2393439851 @default.
- W1603290129 hasRelatedWork W2523044360 @default.
- W1603290129 hasRelatedWork W2561775660 @default.
- W1603290129 hasRelatedWork W2954953689 @default.
- W1603290129 hasRelatedWork W4384562191 @default.
- W1603290129 hasVolume "13" @default.
- W1603290129 isParatext "false" @default.
- W1603290129 isRetracted "false" @default.
- W1603290129 magId "1603290129" @default.
- W1603290129 workType "article" @default.